All stock lists
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
Healthcare · Biotechnology
49.29-0.79 (-1.58%)
Insider Score
––Not scored
TVTX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TVTX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 169.58 M | 127.20 M | 129.69 M | 164.86 M | 114.45 M |
| Revenue Growth (YoY) | 48.17 % | — | — | — | — |
| Cost of Revenue | 9.23 M | 26.77 M | 2.55 M | 1.58 M | 15.16 M |
| Gross Profit | 160.35 M | 100.43 M | 127.14 M | 163.27 M | 99.29 M |
| SG&A Expense | 96.11 M | 80.25 M | 101.69 M | 86.45 M | 62.58 M |
| R&D Expense | 60.28 M | 57.09 M | 57.87 M | 51.89 M | 49.36 M |
| Operating Expenses | 156.40 M | 137.35 M | 159.56 M | 138.34 M | 111.94 M |
| Operating Income | 3.95 M | -36.91 M | -32.43 M | 24.93 M | -12.65 M |
| Pretax Income | -35.00 M | -36.72 M | -21.07 M | 25.71 M | -12.73 M |
| Tax Provision | -204.00 K | -120.00 K | 921.00 K | 8.00 K | 20.00 K |
| Net Income | -34.80 M | -37.10 M | 2.73 M | 25.71 M | -12.76 M |
| EPS (Basic) | -0.37 | -0.40 | 0.03 | 0.29 | -0.14 |
| EPS (Diluted) | -0.37 | -0.40 | 0.03 | 0.28 | -0.14 |
| Shares Outstanding | 93.48 M | 91.87 M | 90.29 M | 89.23 M | 88.95 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.